Full text is available at the source.
Abstract
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may have anti-inflammatory properties that could be relevant for chronic pancreatitis (CP).
- Chronic pancreatitis is marked by irreversible damage to the pancreas and severe pain.
- GLP-1 RAs have shown potential to reduce inflammation in laboratory studies.
- The effect of GLP-1 RAs on clinical outcomes in patients with chronic pancreatitis has not yet been studied.
Simplified